Ser283
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.7
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser283  -  CDX2 (human)

Site Information
RsVPEPLsPVSSLQA   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 456208

In vivo Characterization
Methods used to characterize site in vivo:
mutation of modification site ( 1 )
Relevant cell line - cell type - tissue:

Upstream Regulation
Putative in vivo kinases:
CDK2 (human) ( 1 )
Kinases, in vitro:
CDK2 (human) ( 1 ) , GSK3B (human) ( 1 ) , P38A (human) ( 1 )

Downstream Regulation
Effects of modification on CDX2:
protein degradation ( 1 )

References 

1

Gross I, et al. (2005) Phosphorylation of the homeotic tumor suppressor Cdx2 mediates its ubiquitin-dependent proteasome degradation. Oncogene 24, 7955-63
16027724   Curated Info